- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/94 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving narcotics
Patent holdings for IPC class G01N 33/94
Total number of patents in this class: 1309
10-year publication summary
|
142
|
124
|
145
|
128
|
108
|
127
|
93
|
92
|
79
|
60
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3160 |
28 |
| Hound Labs II, LLC | 34 |
25 |
| The Regents of the University of California | 20842 |
19 |
| Northern Bank Limited | 69 |
19 |
| Siemens Healthcare Diagnostics Inc. | 2150 |
16 |
| ARK Diagnostics, Inc. | 37 |
15 |
| Quest Diagnostics Investments Incorporated | 390 |
15 |
| F. Hoffmann-La Roche AG | 7800 |
14 |
| Labrador Diagnostics LLC | 268 |
14 |
| Becton, Dickinson and Company | 7594 |
13 |
| Takeda Pharmaceutical Company Limited | 2699 |
13 |
| The Florida International University Board of Trustees | 680 |
13 |
| Psychemedics Corporation | 17 |
13 |
| Roche Diagnostics GmbH | 2684 |
9 |
| Roche Diagnostics Operations, Inc. | 1523 |
9 |
| Nutromics Technology Pty Ltd | 47 |
9 |
| MERZ PHARMA GmbH & CO. KGaA | 594 |
8 |
| DH Technologies Development Pte. Ltd. | 1183 |
8 |
| Betterlife Pharma US Inc. | 9 |
8 |
| Antecip Bioventures II LLC | 378 |
7 |
| Other owners | 1034 |